Effects of polypharmacy on sensory, oral, and dietary functions in older adults

Abstract

Aim: Polypharmacy is a major health concern among older adults and is associated with increased vulnerability and adverse health outcomes. However, limited evidence exists regarding its association with sensory, oral, and dietary functions. This study examined the effects of polypharmacy on these functions using nationally representative data from the 2023 Korean Elderly Survey.

Methods: A total of 10,078 community-dwelling adults aged ≥ 65 years were analyzed. Polypharmacy was defined as the use of five or more medications. Sensory function (vision and hearing), oral function (chewing difficulty, swallowing difficulty, denture use, unmet dental needs), and dietary intake (meal frequency, fruit and vegetable consumption) were assessed using structured questionnaires. Chi-square tests and logistic regression analyses were performed. Model 1 adjusted for demographic factors, and Model 2 additionally adjusted for the number of chronic diseases.

Results: Older adults with polypharmacy showed substantially poorer sensory and oral function than those without polypharmacy. Higher prevalence was observed for vision difficulty (60.5% vs. 40.6%), hearing difficulty (48.7% vs. 20.6%), chewing difficulty (58.9% vs. 30.1%), swallowing difficulty (20.9% vs. 6.7%), and unmet dental care needs (9.6% vs. 3.0%) (all p < 0.001). In the fully adjusted model, polypharmacy remained significantly associated with hearing difficulty, chewing difficulty, swallowing difficulty, denture use, and unmet dental care needs. However, associations between polypharmacy and dietary intake indicators were not statistically significant after adjustment.

Conclusions: Polypharmacy is significantly associated with hearing and oral functional impairments among older adults, and these associations were attenuated but not fully explained after adjusting for chronic disease burden. These findings highlight the importance of comprehensive geriatric assessment and multidisciplinary care that integrates medication management and oral health. Strategies promoting rational prescribing and monitoring of functional outcomes are essential to mitigate the adverse effects of polypharmacy and support healthy aging.

Keywords

older adults / polypharmacy / sensory function / oral function / dietary intake

References

[1] Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011; 10: 430-9.

[2] Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014; 13: 57-65.

[3] Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004; 57: 6-14.

[4] Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J Am Med Dir Assoc. 2020; 21: 181-7.

[5] Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012; 65: 989-95.

[6] Fried TR, O’Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review. J Am Geriatr Soc. 2014; 62: 2261-72.

[7] Patterson SM, Cadogan CA, Kerse N, Cardwell CR, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014: CD008165.

[8] Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013; 381: 752-62.

[9] Curhan SG, Shargorodsky J, Eavey R, Curhan GC. Analgesic Use and the Risk of Hearing Loss in Women. Am J Epidemiol. 2012; 176: 544-54.

[10] Fraunfelder FW, Fraunfelder FT. Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects. Ophthalmology. 2004; 111: 1275-9.

[11] Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018; 17: 1185-96.

[12] Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2014; 11: 45-51.

[13] Thomson WM. Dry mouth and older people. Aust Dent J. 2015; 60: 54-63.

[14] Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth-2nd edition. Gerodontology. 1997; 14: 33-47.

[15] Nederfors T, Isaksson R, Mörnstad H, Dahlöf C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population--relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol. 1997; 25: 211-6.

[16] Sheiham A, Steele JG, Marcenes W, Lowe C, Finch S, Bates CJ, et al. The Relationship among Dental Status, Nutrient Intake, and Nutritional Status in Older People. J Dent Res. 2001; 80: 408-13.

[17] Sawada N, Takeuchi N, Ekuni D, Morita M. Effect of oral health status and oral function on malnutrition in community-dwelling older adult dental patients: A two-year prospective cohort study. Gerodontology. 2024; 41: 393-9.

[18] Nowjack-Raymer RE, Sheiham A. Association of Edentulism and Diet and Nutrition in US Adults. J Dent Res. 2003; 82: 123-6.

[19] Tsakos G, Watt RG, Rouxel PL, de Oliveira C, Demakakos P. Tooth Loss Associated with Physical and Cognitive Decline in Older Adults. J Am Geriatr Soc. 2015; 63: 91-9.

[20] Iwasaki M, Yoshihara A, Ito K, Sato M, Minagawa K, Muramatsu K, et al. Hyposalivation and dietary nutrient intake among community-based older Japanese. Geriatr Gerontol Int. 2016; 16: 500-7.

[21] Morley JE. Undernutrition in older adults. Fam Pract. 2012; 29: i89-93.

[22] Volkert D, Beck AM, Cederholm T, Cereda E, Cruz-Jentoft A, Goisser S, et al. Management of Malnutrition in Older Patients-Current Approaches, Evidence and Open Questions. J Clin Med. 2019; 8: 974.

[23] Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. The benefits and harms of deprescribing. Med J Aust. 2014; 201: 386-9.

[24] Pedersen A, Sørensen CE, Proctor GB, Carpenter GH. Salivary functions in mastication, taste and textural perception, swallowing and initial digestion. Oral Dis. 2018; 24: 1399-416.

[25] Watanabe D, Yoshida T, Watanabe Y, Yokoyama K, Yamada Y, Kikutani T, et al. Oral frailty is associated with mortality independently of physical and psychological frailty among older adults. Exp Gerontol. 2024; 191: 112446.

[26] Kang MG, Jung HW. Association Between Oral Health and Frailty in Older Korean Population: A Cross-Sectional Study. Clin Interv Aging. 2022; 17: 1863-72.

[27] Yin Z, Fei Z, Qiu C, Brasher MS, Kraus VB, Zhao W, et al. Dietary diversity and cognitive function among elderly people: A population-based study. J Nutr Health Aging. 2017; 21: 1089-94.

[28] Cho HJ, Chae J, Yoon SH, Kim DS. Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010-2019. Front Pharmacol. 2022; 13: 866318.

[29] Tanaka T, Takahashi K, Hirano H, Kikutani T, Watanabe Y, et al. Oral Frailty as a Risk Factor for Physical Frailty and Mortality in Community-Dwelling Elderly. Geriatr Gerontol Int. 2018; 18: 1661-7.

[30] Kusunoki H, Hasegawa Y, Nagasawa Y, Shojima K, Yamazaki H, Mori T, et al. Oral Frailty and Its Relationship with Physical Frailty in Older Adults: A Longitudinal Study Using the Oral Frailty Five-Item Checklist. Nutrients. 2025; 17: 17.

[31] Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020; 396: 413-46.

[32] Lin FR, Yaffe K, Xia J, Xue QL, Harris TB, Purchase-Helzner E, et al.; Health ABC Study Group. Hearing Loss and Cognitive Decline in Older Adults. JAMA Intern Med. 2013; 173: 293-9.

[33] Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero Á, Inzitari M, Martínez-Velilla N, et al. The relationship between frailty and polypharmacy in older people: a systematic review. Age Ageing. 2018; 84: 1432-44.

[34] Vetrano DL, Palmer K, Marengoni A, Marzetti E, Lattanzio F, Roller-Wirnsberger R, et al.; Joint Action ADVANTAGE WP4 Group. Frailty and Multimorbidity: A Systematic Review and Meta-analysis. J Gerontol A Biol Sci Med Sci. 2019; 74: 659-66.

[35] Huang J, Zhang Y, Xv M, Sun L, Wang M. Association between oral health status and frailty in older adults: a systematic review and meta-analysis. Front Public Health. 2025; 13: 1514623.

[36] Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015; 175: 827-34.